person · Reporting owner
Mariano Eleanor Concepcion
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeMD, Inc.LFMD · Entity 6521 | Director | September 20, 2021 | September 21, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeMD, Inc.
Report date September 20, 2021 · Filed September 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 8,000 |
Reported balance
After 2021-09-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-09-20 · Grant · Acquired 8,000 · Balance 8,000 F1: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022. |
| Common Stock, par value $0.01SEC Table I · non-derivative | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 20,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2021 Filed Sep 21, 2021 21:22 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantRestricted Stock Unit · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-023280 · ownership.xml · derivative · entry 2 Mariano Eleanor Concepcion · CIK 0001833257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock, par value $0.01 · 8,000 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.